Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 45551-45600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06109142
Clearance of Vasoactive Metabolites With Blood Purification
N/A
Recruiting
30 participants
Started: Jul 11, 2024 · Completed: Jun 11, 2026
1 condition
1 sponsor
3 locations
NCT06091202
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
PHASE3
Recruiting
608 participants
Started: Jul 11, 2024 · Completed: Jun 1, 2027
1 condition
6 sponsors
4 locations
NCT06505837
JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer(NSCLC)
PHASE3
Active, not recruiting
395 participants
Started: Jul 11, 2024 · Completed: Dec 30, 2026
1 condition
2 sponsors
1 location
NCT07145138
UIC Multi-Ethnic DCM Registry
N/A
Recruiting
1,500 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2038
2 conditions
1 sponsor
1 location
NCT06374875
Fibrosis Lessens After Metabolic Surgery
PHASE4
Recruiting
120 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2029
5 conditions
2 sponsors
22 locations
NCT06515795
Evaluation of Two Isometric Exercises in the Reduction of the Blood Pressure in People With Resistant Hypertension
NA
Recruiting
15 participants
Started: Jul 11, 2024 · Completed: Sep 30, 2024
1 condition
2 sponsors
1 location
NCT05662462
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
NA
Recruiting
124 participants
Started: Jul 11, 2024 · Completed: Mar 31, 2029
4 conditions
3 sponsors
1 location
NCT06069648
Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening
NA
Not yet recruiting
270 participants
Started: Jul 11, 2024 · Completed: Mar 10, 2026
1 condition
1 sponsor
0 locations
NCT06500819
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
PHASE1
Recruiting
41 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2029
3 conditions
1 sponsor
1 location
NCT06601309
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
PHASE2
Recruiting
90 participants
Started: Jul 11, 2024 · Completed: Dec 1, 2026
1 condition
1 sponsor
1 location
NCT07019584
"Wai Ji Match Fun Card Games for People With Intellectual Disabilities"
NA
Active, not recruiting
60 participants
Started: Jul 11, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06319846
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
PHASE3
Recruiting
4,674 participants
Started: Jul 11, 2024 · Completed: Dec 31, 2026
3 conditions
1 sponsor
5 locations
NCT06513234
Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas
PHASE2
Recruiting
45 participants
Started: Jul 11, 2024 · Completed: Jun 21, 2029
1 condition
1 sponsor
1 location
NCT06046443
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity
PHASE2
Active, not recruiting
28 participants
Started: Jul 11, 2024 · Completed: Jan 31, 2026
1 condition
1 sponsor
10 locations
NCT06507579
Hydra Registry - UK
N/A
Recruiting
250 participants
Started: Jul 11, 2024 · Completed: Aug 1, 2026
1 condition
2 sponsors
4 locations
NCT06558981
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
PHASE3
Recruiting
124 participants
Started: Jul 11, 2024 · Completed: Jun 30, 2031
1 condition
1 sponsor
1 location
NCT06562114
A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment
PHASE1
Recruiting
72 participants
Started: Jul 11, 2024 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT06441591
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
PHASE2/PHASE3
Recruiting
64 participants
Started: Jul 10, 2024 · Completed: Jun 1, 2025
2 conditions
1 sponsor
2 locations
NCT06324812
Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis
PHASE1/PHASE2
Recruiting
124 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06515613
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
PHASE1
Recruiting
80 participants
Started: Jul 10, 2024 · Completed: Mar 31, 2028
3 conditions
1 sponsor
8 locations
NCT06420076
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
PHASE1/PHASE2
Recruiting
60 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2026
6 conditions
1 sponsor
1 location
NCT06681688
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
PHASE1/PHASE2
Recruiting
94 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2025
1 condition
2 sponsors
2 locations
NCT06473948
To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects
PHASE1
Not yet recruiting
27 participants
Started: Jul 10, 2024 · Completed: Feb 27, 2025
1 condition
1 sponsor
0 locations
NCT06709755
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
NA
Recruiting
360 participants
Started: Jul 10, 2024 · Completed: Mar 15, 2029
1 condition
3 sponsors
1 location
NCT06213636
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
PHASE1/PHASE2
Recruiting
75 participants
Started: Jul 10, 2024 · Completed: Dec 10, 2028
7 conditions
1 sponsor
1 location
NCT06681883
Implementation of the Model of Modifiable Factors Specific to Problematic Internet Use in Adolescents
NA
Enrolling by invitation
10 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2025
2 conditions
1 sponsor
1 location
NCT06208657
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
PHASE1/PHASE2
Recruiting
82 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2035
5 conditions
6 sponsors
11 locations
NCT06791148
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
PHASE2
Recruiting
45 participants
Started: Jul 10, 2024 · Completed: Dec 10, 2027
1 condition
1 sponsor
1 location
NCT06350110
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
PHASE1/PHASE2
Recruiting
75 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2025
9 conditions
1 sponsor
1 location
NCT06497946
Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women
NA
Recruiting
64 participants
Started: Jul 10, 2024 · Completed: Nov 30, 2025
3 conditions
1 sponsor
1 location
NCT06363721
A Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental Health
NA
Recruiting
18 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06498050
Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema
PHASE4
Active, not recruiting
52 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
1 condition
2 sponsors
1 location
NCT06420063
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
PHASE1/PHASE2
Recruiting
85 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2026
4 conditions
1 sponsor
1 location
NCT06512311
Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
NA
Recruiting
240 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2031
1 condition
1 sponsor
1 location
NCT06187103
Evaluation of Improved Onboard Patient Imaging
NA
Recruiting
40 participants
Started: Jul 10, 2024 · Completed: Oct 31, 2025
5 conditions
1 sponsor
1 location
NCT06274294
Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC
PHASE3
Recruiting
130 participants
Started: Jul 10, 2024 · Completed: Jan 31, 2025
1 condition
3 sponsors
1 location
NCT06247111
Monitoring Blood Pressure at Home
NA
Active, not recruiting
24 participants
Started: Jul 10, 2024 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT06130514
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
NA
Not yet recruiting
118 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2026
5 conditions
1 sponsor
0 locations
NCT06557642
Nitrous Oxide and EMOtional Cognition
NA
Recruiting
88 participants
Started: Jul 10, 2024 · Completed: Oct 1, 2025
1 condition
1 sponsor
1 location
NCT06547086
Rapid Eye Movement Restoration and Enhancement for Sleep-deprived Trauma-adaptation
NA
Recruiting
80 participants
Started: Jul 10, 2024 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT06330025
Exploring Food Rejection Dispositions as Potential Risk Factors for Undernutrition in Hospitalized Children Aged 2 to 8
N/A
Recruiting
102 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2026
1 condition
1 sponsor
1 location
NCT06753383
Effectiveness of Virtual Reality- Based Rehabilitation Program in Individuals With Adolescent Idiopathic Scoliosis After Posterior Fusion Surgery
NA
Enrolling by invitation
28 participants
Started: Jul 10, 2024 · Completed: Jul 21, 2025
1 condition
2 sponsors
1 location
NCT06046742
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
12 participants
Started: Jul 10, 2024 · Completed: Dec 20, 2026
1 condition
1 sponsor
3 locations
NCT06490419
Effect of Ultrasound Cavitation Versus Electrolipolysis on Obese Infertile Women With Polycystic Ovarian Syndrome
NA
Not yet recruiting
30 participants
Started: Jul 10, 2024 · Completed: Dec 10, 2024
1 condition
1 sponsor
0 locations
NCT06377527
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
N/A
Recruiting
2,000 participants
Started: Jul 10, 2024 · Completed: Dec 28, 2037
1 condition
1 sponsor
1 location
NCT06496308
Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment
PHASE3
Recruiting
78 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2027
1 condition
9 sponsors
1 location
NCT06507761
Thermotherapy in Acute Nonspecific Neck Pain
NA
Recruiting
60 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
2 conditions
1 sponsor
2 locations
NCT06683690
TGF β 1 Expression Related Gene Polymorphism
N/A
Recruiting
60 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
1 condition
1 sponsor
1 location
NCT05901194
Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma
PHASE1/PHASE2
Active, not recruiting
25 participants
Started: Jul 10, 2024 · Completed: Apr 30, 2027
1 condition
2 sponsors
6 locations
NCT06851676
Functional and Metabolic Effects of Fonte Fausta® Water on Bone and Muscle Health in Osteoporotic Patients
NA
Recruiting
100 participants
Started: Jul 10, 2024 · Completed: Sep 10, 2025
2 conditions
2 sponsors
1 location
Previous
1
More pages
909
910
911
912
913
914
915
More pages
2369
Next